Medeon Biodesign Announces Successful Clinical Use of AbClose(TM) Laparoscopic Port Site Closure Device in the United States
TAIPEI, , Oct. 20, 2017 /PRNewswire/ -- Medeon Biodesign, Inc., a publicly traded medical device company headquartered inTaipei, is pleased to announce that its innovative laparoscopic port site closure device, AbClose™, successfully closed more than 50 wounds in a variety of laparoscopic surgeri...
2017-10-20 15:00
1792
Medeon Biodesign Announces Approval to Begin CE Clinical Study for the XPro(TM) Large Bore Vascular Closure System
TAIPEI, , May 2, 2017 /PRNewswire/ -- Medeon Biodesign, Inc., a Taiwan publically traded medical device company, is pleased to announce today that it has received approval by the Health and Disability Ethics Committees, Ministry of Health,New Zealand to commence the CE clinical trial for the XPro...
2017-05-02 15:00
2806
